ロード中...

Gleevec/imatinib, an ABL2 kinase inhibitor, protects tumor and endothelial cells from semaphorin-induced cytoskeleton collapse and loss of cell motility

Class 3 semaphorins are axonal guidance mediators and regulators of angiogenesis and tumor progression Semaphorin 3A and 3F (SEMA3A&F) act by depolymerizing F-actin, resulting in cytoskeleton collapse A key signaling step is that SEMA3A&F activates ABL2 tyrosine kinase, which activates p190R...

詳細記述

保存先:
書誌詳細
主要な著者: Procaccia, Vera, Nakayama, Hironao, Shimizu, Akio, Klagsbrun, Michael
フォーマット: Artigo
言語:Inglês
出版事項: 2014
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4068341/
https://ncbi.nlm.nih.gov/pubmed/24759231
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbrc.2014.04.063
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!